Follow
Anna  Montanaro
Anna Montanaro
Verified email at unipr.it
Title
Cited by
Cited by
Year
Venetoclax and bortezomib in relapsed/refractory early T-cell precursor acute lymphoblastic leukemia
R La Starza, B Cambò, A Pierini, B Bornhauser, A Montanaro, ...
JCO precision oncology 3, 2019
342019
Blockade of oncogenic NOTCH1 with the SERCA inhibitor CAD204520 in T cell acute lymphoblastic leukemia
M Marchesini, A Gherli, A Montanaro, L Patrizi, C Sorrentino, L Pagliaro, ...
Cell chemical biology 27 (6), 678-697. e13, 2020
312020
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia
A Montanaro, S Kitara, E Cerretani, M Marchesini, C Rompietti, L Pagliaro, ...
Cell Death & Disease 13 (6), 551, 2022
62022
P336: a chemotranscriptomic screening identifies the reversal of glucocorticoid resistance in notch1 mutated T-ALL
L Pagliaro, LM Dalla Tor, V Federica, P Andrei, L Monica, S Kleissle, ...
HemaSphere 6, 236-237, 2022
12022
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders
L Pagliaro, E Cerretani, F Vento, A Montanaro, L Moron Dalla Tor, ...
International Journal of Molecular Sciences 25 (2), 766, 2024
2024
Pathogenetic mechanisms in the Darier disease (DD): a gene expression and protein interactions' study
E De Sensi, A Croce, IR Cannizzaro, A Taiani, M Di Capo, D Martorana, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 32, 143-143, 2024
2024
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia
A Montanaro, A D'Antuono, LM Dalla Tor, P Andrei, F Cavazzini, ...
Blood 142, 118, 2023
2023
P324: CELL PLASTICITY PREDETERMINES TREATMENT RESPONSE IN T-ALL
V Dimitrova, J Frede, A Montanaro, S Potdar, H Stuart, N Sotoudeh, ...
HemaSphere 7 (S3), e0988081, 2023
2023
S188: CAR-T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE TUMOR MICROENVIRONMENT
J Frede, J Poller, K Shi, H Stuart, N Sotoudeh, K Lim, C Wiggers, ...
HemaSphere 7 (Suppl), 2023
2023
Cellular Plasticity As Mechanisms to Escape from NOTCH1-Inhibition in T-ALL
V Dimitrova, N Sotudeh, B Knoechel, JG Lohr, A Montanaro, SV Potdar, ...
Blood 140 (Supplement 1), 3461-3462, 2022
2022
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia
A Montanaro, A D'Antuono, L Moron Dalla Tor, P Andrei, A Ciringione, ...
Blood 140 (Supplement 1), 3130-3131, 2022
2022
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML
M Marchesini, A Gherli, E Simoncini, A Montanaro, N Thongon, L Pagliaro, ...
Blood 140 (Supplement 1), 673-674, 2022
2022
Identificazione di una dipendenza epi-metabolica da EHMT2/G9a in Leucemia linfoblastica acuta a cellule T
A Montanaro
Università degli studi di Parma. Dipartimento di Medicina e chirurgia, 2022
2022
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL
L Pagliaro, L Dalla Tor, L Monica, P Andrei, F Vento, E Simoncini, ...
HAEMATOLOGICA 107, 19-19, 2022
2022
Maturity State and MCL-1 Dependence Predetermines Response to NOTCH1 Inhibition in T-ALL
V Dimitrova, N Sotudeh, A Montanaro, H Yun, SV Potdar, A Van Scoyk, ...
Blood 138 (Supplement 1), 3484-3484, 2021
2021
Poster: ALL-043: Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia
M Marchesini, A Gherli, AML Winter, S Kitara, A Montanaro, L Pagliaro, ...
Clinical Lymphoma Myeloma and Leukemia 21, S205, 2021
2021
ALL-043: Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia
M Marchesini, A Gherli, AML Winter, S Kitara, A Montanaro, L Pagliaro, ...
Clinical Lymphoma Myeloma and Leukemia 21, S263-S264, 2021
2021
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520
M Marchesini, A Gherli, A Montanaro, C Sorrentino, L Pagliaro, ...
HAEMATOLOGICA 105, S46-S47, 2020
2020
Abstract B113: Selective blockade of oncogenic NOTCH1 with the new SERCA inhibitor CAD204520 in T-cell acute lymphoblastic leukemia
M Matteo, A Gherli, AML Winter, S Kitara, A Montanaro, C Rompietti, ...
Molecular Cancer Therapeutics 18 (12_Supplement), B113-B113, 2019
2019
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520
M Marchesini, A Gherli, A Montanaro, S Kitara, C Sorrentino, L Pagliaro, ...
Blood 134, 407, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20